UBS Group’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $15.8M | Buy |
751,905
+301,758
| +67% | +$6.34M | ﹤0.01% | 2061 |
|
2025
Q1 | $7.37M | Buy |
450,147
+31,662
| +8% | +$519K | ﹤0.01% | 2638 |
|
2024
Q4 | $10.8M | Buy |
418,485
+278,938
| +200% | +$7.17M | ﹤0.01% | 2262 |
|
2024
Q3 | $4.42M | Sell |
139,547
-89,258
| -39% | -$2.83M | ﹤0.01% | 2380 |
|
2024
Q2 | $8.03M | Sell |
228,805
-14,244
| -6% | -$500K | ﹤0.01% | 1763 |
|
2024
Q1 | $10.7M | Buy |
243,049
+92,347
| +61% | +$4.05M | ﹤0.01% | 1570 |
|
2023
Q4 | $5.36M | Buy |
150,702
+94,167
| +167% | +$3.35M | ﹤0.01% | 1955 |
|
2023
Q3 | $1.53M | Buy |
56,535
+47,486
| +525% | +$1.28M | ﹤0.01% | 2761 |
|
2023
Q2 | $213K | Sell |
9,049
-47,405
| -84% | -$1.11M | ﹤0.01% | 4409 |
|
2023
Q1 | $775K | Sell |
56,454
-58,149
| -51% | -$798K | ﹤0.01% | 3377 |
|
2022
Q4 | $2.08M | Buy |
114,603
+99,753
| +672% | +$1.81M | ﹤0.01% | 2535 |
|
2022
Q3 | $222K | Buy |
14,850
+10,244
| +222% | +$153K | ﹤0.01% | 3983 |
|
2022
Q2 | $64K | Sell |
4,606
-71,765
| -94% | -$997K | ﹤0.01% | 4739 |
|
2022
Q1 | $854K | Sell |
76,371
-40,996
| -35% | -$458K | ﹤0.01% | 3380 |
|
2021
Q4 | $2.77M | Buy |
117,367
+72,996
| +165% | +$1.73M | ﹤0.01% | 2618 |
|
2021
Q3 | $1.13M | Buy |
44,371
+21,160
| +91% | +$539K | ﹤0.01% | 3163 |
|
2021
Q2 | $487K | Buy |
23,211
+10,846
| +88% | +$228K | ﹤0.01% | 3772 |
|
2021
Q1 | $291K | Buy |
12,365
+11,506
| +1,339% | +$271K | ﹤0.01% | 4266 |
|
2020
Q4 | $12K | Buy |
859
+601
| +233% | +$8.4K | ﹤0.01% | 6321 |
|
2020
Q3 | $3K | Sell |
258
-3,557
| -93% | -$41.4K | ﹤0.01% | 6647 |
|
2020
Q2 | $54K | Buy |
3,815
+3,113
| +443% | +$44.1K | ﹤0.01% | 4952 |
|
2020
Q1 | $3K | Buy |
+702
| New | +$3K | ﹤0.01% | 6565 |
|
2019
Q4 | – | Sell |
-3,023
| Closed | -$27K | – | 7092 |
|
2019
Q3 | $27K | Buy |
+3,023
| New | +$27K | ﹤0.01% | 5587 |
|